ライフサイエンスコーパス: supraventricular tachycardia

1 ew consistent associations were observed for supraventricular tachycardia.

2 tions, and shocks for atrial fibrillation or supraventricular tachycardia.

3 ablation of atrioventricular nodal reentrant supraventricular tachycardia.

4 expensive treatment option for many forms of supraventricular tachycardia.

5 iofrequency ablation to treat other types of supraventricular tachycardia.

6 e while receiving long-term drug therapy for supraventricular tachycardia.

7 l tachycardia from other forms of paroxysmal supraventricular tachycardia.

8 s uncommon, occurring in 1% of patients with supraventricular tachycardia.

9 ymptom (42.2%), followed by heart murmur and supraventricular tachycardia.

10 low-up (1 to 7 years) of patients with fetal supraventricular tachycardia.

11 ats (166 [5.3%] versus 265 [8.3%]; P<0.001), supraventricular tachycardia (1413 [44.7%] versus 1752 [

12 entricular fibrillation (62%), AF (23%), and supraventricular tachycardia (15%).

13 0 consecutive patients presenting with fetal supraventricular tachycardia (17 managed prenatally, 13

14 ions converted 14 of 15 (93%) with reentrant supraventricular tachycardia, 2 of 2 with ventricular or

15 versus 0.86 [95% CI, 0.28-1.75]; P=0.07) and supraventricular tachycardia (20 [95% CI, 12-31] versus

16 r for inappropriate shock (44%), followed by supraventricular tachycardia (36%), and then abnormal se

17 469; p < .0001) among initial rhythms, i.e., supraventricular tachycardia (60.7%), ventricular tachyc

18 In patients with supraventricular tachycardia, a modified Valsalva manoeu

19 radiofrequency ablation of various forms of supraventricular tachycardia after Mustard and Senning o

20 of primary adverse events for patients with supraventricular tachycardia and ventricular tachycardia

21 2%) of 81 (95% confidence interval, 0.3%-9%) supraventricular tachycardia and ventricular tachycardia

22 tained monomorphic VT, 20 polymorphic VT, 10 supraventricular tachycardia, and 3 malsensing episodes.

23 requent arrhythmia experienced in childhood, supraventricular tachycardia, and its variants.

24 Most cases of supraventricular tachycardia are not life-threatening; t

25 Supraventricular tachycardias are less common and are us

26 The low incidence of SCD and low risk of supraventricular tachycardia argue against routine invas

27 e the electrophysiologic mechanisms of fetal supraventricular tachycardia at presentation and postnat

28 an internationally recommended treatment for supraventricular tachycardia, but cardioversion is rare

29 Fetal supraventricular tachycardia causes significant fetal an

30 No supraventricular tachycardias converted to VT or ventric

31 y decreased the risk of atrial fibrillation, supraventricular tachycardia, deep vein thrombosis, resp

32 ithm; ventricular tachycardia/diagnosis; and supraventricular tachycardia/diagnosis.

33 thms with rates of 182 to 250 beats/min, and supraventricular tachycardia discriminators were used fo

34 proved highly effective for the treatment of supraventricular tachycardia during childhood and adoles

35 ardia, sustained ventricular tachycardia, or supraventricular tachycardia during dobutamine infusion

36 One patient developed supraventricular tachycardia during pregnancy and had co

37 One patient developed supraventricular tachycardia during the additional 2 min

38 We randomly allocated adults presenting with supraventricular tachycardia (excluding atrial fibrillat

39 Sustained supraventricular tachycardia (> 12 h) and lower gestatio

40 er first shocks due to sinus tachycardia and supraventricular tachycardia (HR: 0.97, p = 0.86) and no

41 01) and increases in hospitalizations for AF/supraventricular tachycardia (HR: 1.38; 95% CI: 1.35 to

42 hree requiring hospital admission (sustained supraventricular tachycardia, hypotension, suspected myo

43 Adenosine, the standard therapy for treating supraventricular tachycardia in children and adults with

44 pic tachycardia is a common cause of chronic supraventricular tachycardia in children and can be resi

45 al tachycardia (FAT) is an uncommon cause of supraventricular tachycardia in children.

46 Supraventricular tachycardia in infants can be refractor

47 lysis was to define the incidence of SCD and supraventricular tachycardia in patients with asymptomat

48 tachycardia was the predominant mechanism of supraventricular tachycardia in the fetus.

49 patients developed 38 relapses of paroxysmal supraventricular tachycardia in the ICU after initial co

50 rdiovascular complications during pregnancy: supraventricular tachycardia in two, heart failure in tw

51 The odds of supraventricular tachycardia increased by a factor of 36

52 ory pathway effective refractory periods and supraventricular tachycardia inducibility in recent inva

53 entriculoatrial conduction during paroxysmal supraventricular tachycardia is a useful diagnostic mane

54 hat the mechanism responsible for paroxysmal supraventricular tachycardia is atrial reentry utilizing

55 Supraventricular tachycardia is common after heart trans

56 ry fetal tachycardia, specifically reentrant supraventricular tachycardia, junctional ectopic, or ven

57 though long-term management of most forms of supraventricular tachycardia lies primarily in the realm

58 The fetal supraventricular tachycardia mechanism was 1:1 atriovent

59 The supraventricular tachycardia mechanism was typical slow/

60 analysis and postnatal confirmation of fetal supraventricular tachycardia mechanisms have been limite

61 Supraventricular tachycardia mechanisms were evaluated b

62 n (n = 4), ventricular fibrillation (n = 6), supraventricular tachycardia (n = 1), and polymorphic ve

63 Clinical variables associated with SCD were supraventricular tachycardia (odds ratio [OR], 3.5; 95%

64 ia (VT); 3) pre-excitation; and 4) sustained supraventricular tachycardia of any mechanism.

65 low-up ranging from 8 to 96 months), regular supraventricular tachycardia or benign atrial fibrillati

66 centages of both VT/VF (22.3% vs. 28.7%) and supraventricular tachycardia or other non-VT/VF event ep

67 vent free, except for an isolated episode of supraventricular tachycardia, over an average 6-year fol

68 related to survival when initial rhythm was supraventricular tachycardia (p = .04), negatively relat

69 care physician must have a keen awareness of supraventricular tachycardia patterns, mechanisms, preci

70 pacing maneuvers in patients with paroxysmal supraventricular tachycardia (PSVT) in the electrophysio

71 logy and clinical significance of paroxysmal supraventricular tachycardia (PSVT) in the general popul

72 and efficacy during conversion of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm.

73 with documented but noninducible paroxysmal supraventricular tachycardia (PSVT) who have evidence of

74 Tecadenoson terminates induced paroxysmal supraventricular tachycardia (PSVT) without the clinical

75 Among patients who have monthly episodes of supraventricular tachycardia, radiofrequency ablation wa

76 erwent 13 studies to successfully ablate all supraventricular tachycardia substrates in eight (73%) p

77 We reviewed supraventricular tachycardia (SVT) ablation in adult pat

78 Supraventricular tachycardia (SVT) causing heart failure

79 management, including catheter ablation, of supraventricular tachycardia (SVT) in a large series of

80 and sotalol for the treatment of refractory supraventricular tachycardia (SVT) in children <1 year o

81 progression of CHF caused by pacing-induced supraventricular tachycardia (SVT) in pigs.

82 Supraventricular tachycardia (SVT) is one of the most co

83 leven additional patients were recruited for supraventricular tachycardia (SVT) mapping, and seven of

84 appropriate shocks caused by misdetection of supraventricular tachycardia (SVT) remains a substantial

85 patients (8 male; age, 30.5+/-8 years) with supraventricular tachycardia (SVT) underwent catheter ab

86 e syndrome, recurrent episodes of paroxysmal supraventricular tachycardia (SVT) were analyzed to dete

87 lar rhythms, and inappropriate therapies for supraventricular tachycardia (SVT) were compared among 5

88 AF), and 30 patients undergoing ablation for supraventricular tachycardia (SVT) were compared with a

89 and 25 with various arrhythmias: 9 reentrant supraventricular tachycardia (SVT), 2 ventricular tachyc

90 00 PVCs, 74 (42%) had couplets, 67 (37%) had supraventricular tachycardia (SVT), and 56 (31%) had non

91 atrial fibrillation, all classifications of supraventricular tachycardia (SVT), and stroke among old

92 ced atrial fibrillation (AF)/atrial flutter, supraventricular tachycardia (SVT), or AE.

93 nitiation and termination of reentrant fetal supraventricular tachycardia (SVT), the most common form

94 llation (VF), and 1368 episodes (n=149) were supraventricular tachycardia (SVT).

95 r systole on the hemodynamic response during supraventricular tachycardia (SVT).

96 in adults, it accounts for 13% of pediatric supraventricular tachycardia (SVT).

97 with tachycardia mechanisms in patients with supraventricular tachycardias (SVT).

98 ers are associated with a lower incidence of supraventricular tachycardias (SVTs) and ventricular arr

99 ical atrioventricular node-dependent long RP supraventricular tachycardias (SVTs) can be challenging.

100 ould be more pronounced during an episode of supraventricular tachycardia than during normal rhythm.

101 From the fetus with supraventricular tachycardia to the adolescent with vaso

102 d diagnostic criteria were used to determine supraventricular tachycardia type.

103 effectively and safely performed for certain supraventricular tachycardia types in addition to intraa

104 ode examination that required application of supraventricular tachycardia, ventricular fibrillation,

105 The risk of supraventricular tachycardia was 16 (95% CI, 10-24) even

106 A total of 156 supraventricular tachycardias were reported involving 98

107 total of 69% of patients were cannulated for supraventricular tachycardia with a median rate of 230 b

108 ardia (LPF-VT) is frequently misdiagnosed as supraventricular tachycardia with aberrant right bundle

109 rioventricular conduction in 22 patients and supraventricular tachycardia with atrioventricular block

110 There was a high association of supraventricular tachycardia with atrioventricular block

111 In 44 patients with supraventricular tachycardia with no history of AF or ri

112 more importantly, in the definitive cure of supraventricular tachycardia with the use of catheter ab

113 Three other patients had supraventricular tachycardias, with success in two and n

114 noson appears to terminate AV node-dependent supraventricular tachycardias without hypotension and br